1999
DOI: 10.1093/biomet/86.2.365
|View full text |Cite
|
Sign up to set email alerts
|

Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes

Abstract: We study the combined impact that all-or-none compliance and subsequent missing outcomes can have on the estimation of the intention-to-treat effect of assignment in randomised studies. In this setting, a standard analysis, which drops subjects with missing outcomes and ignores compliance information, can be biased for the intention-to-treat effect. To address all-or-none compliance that is followed by missing outcomes, we construct a new estimation procedure for the intention-to-treat effect that maintains go… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
382
0
1

Year Published

2002
2002
2015
2015

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 352 publications
(385 citation statements)
references
References 28 publications
2
382
0
1
Order By: Relevance
“…Any change in context will lead to a different CACE, therefore limiting the clinical usefulness of the PS approach. As a concrete example, when controls do not have access to active treatment in the study, the current PS method (and any instrumental variable estimator) states that there are no ATs [8,21]. However, once the active treatment is approved, ATs will very likely exist, and the CACE will be different due to the change in the membership of the BC stratum.…”
Section: Challenges and Possible Approaches To A Solutionmentioning
confidence: 99%
“…Any change in context will lead to a different CACE, therefore limiting the clinical usefulness of the PS approach. As a concrete example, when controls do not have access to active treatment in the study, the current PS method (and any instrumental variable estimator) states that there are no ATs [8,21]. However, once the active treatment is approved, ATs will very likely exist, and the CACE will be different due to the change in the membership of the BC stratum.…”
Section: Challenges and Possible Approaches To A Solutionmentioning
confidence: 99%
“…Other methods exist for correcting this kind of sample selection issue including principal stratification (Frangakis & Rubin, 1999), instrumental variables adjustment (Angrist, Imbens, & Rubin, 1996), propensity score matching or adjustment (Rosenbaum & Rubin, 1983), Heckman's method for selection correction (Heckman, 1976), and Bayesian methods (Imbens & Rubin, 1997). Unfortunately, each of these methods impose assumptions upon the data, they can produce conflicting results, and their use may fail to produce unbiased estimates of treatment effects (Holland, 1989;LaLonde & Maynard, 1987;Little, 1985;Murnane, Newstead, & Olsen, 1985;Wainer, 1986).…”
Section: Sample Selection Issues For Impacts On Ogt Retake Performancementioning
confidence: 99%
“…Yau and Little (2001) demonstrated the simultaneous modeling of noncompliance and nonresponse using the ML-EM and Bayesian estimation methods, assuming no correlation between noncompliance and nonresponse (i.e., missing at random; Little & Rubin, 1987). Frangakis and Rubin (1999) demonstrated the simultaneous modeling of noncompliance and nonresponse using Bayesian estimation methods, allowing for possible correlation between noncompliance and nonresponse (i.e., missing not at random; Little & Rubin, 1987). Statistical power will be affected not only depending on whether this missingness is taken into account, but also depending on what is assumed for the relationship between noncompliance and nonresponse.…”
Section: Limitationsmentioning
confidence: 99%